TRV GP IV, LLC Long-Term Concentrated

CIK: 0001688325 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 5, 2021

Total Value ($000): $440,740 (100.0% shares, 0.0% debt)

Holdings (5)

TNGX TANGO THERAPEUTICS, INC. 56.8%

Value ($000) $250,376 Shares 19,363,975 Est. Cost $11.99 Unrealized 0.0%

FULC FULCRUM THERAPEUTICS, INC. 15.0%

Value ($000) $66,100 Shares 2,343,154 Est. Cost $11.06 Unrealized +71.3%

— MAGENTA THERAPEUTICS, INC. 11.2%

Value ($000) $49,200 Shares 6,758,204 Est. Cost $5.70 Unrealized —

RVMD REVOLUTION MEDICINES, INC. 8.9%

Value ($000) $39,061 Shares 1,419,900 Est. Cost $27.68 Unrealized +5.1%

PLRX PLIANT THERAPEUTICS, INC. 8.2%

Value ($000) $36,003 Shares 2,132,867 Est. Cost $26.54 Unrealized -20.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
TNGX	TANGO THERAPEUTICS, INC.	19,363,975	$250,376	56.8%	$11.99	0.0%	COM	87583X109
FULC	FULCRUM THERAPEUTICS, INC.	2,343,154	$66,100	15.0%	$11.06	+71.3%	COM	359616109
—	MAGENTA THERAPEUTICS, INC.	6,758,204	$49,200	11.2%	$5.70	—	COM	55910K108
RVMD	REVOLUTION MEDICINES, INC.	1,419,900	$39,061	8.9%	$27.68	+5.1%	COM	76155X100
PLRX	PLIANT THERAPEUTICS, INC.	2,132,867	$36,003	8.2%	$26.54	-20.0%	COM	729139105